APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Pain Medication

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Veterinary Pain Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

21 December 2025193 pages

Choose your research edition.

Industry ResearchVeterinary Pain Medication Industry Research Report 2026132 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Pain Medication Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Veterinary Pain Medication Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Pain Medication Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Pain Medication Market Analysis and Forecast 2026-2032207 pages · $4,950 USD

Market perspective

The global Veterinary Pain Medication market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Veterinary Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Veterinary Pain Medication is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Veterinary Pain Medication include Zoetis, Ringpu Bio-technology, Ruicheng Lvman Biological Pharmaceutical Co., Ltd., Merck & Co, Medtronic, Lilly, Pfizer, Harbin Bolai Pharmaceutical Co., Ltd. and Bostonscientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary Pain Medication market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Pain Medication and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Pain Medication sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Pain Medication market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Pain Medication Segment by Company

Zoetis

Ringpu Bio-technology

Ruicheng Lvman Biological Pharmaceutical Co., Ltd.

Merck & Co

Medtronic

Lilly

Pfizer

Harbin Bolai Pharmaceutical Co., Ltd.

Bostonscientific

Bayer Pharma AG

Baxter

Norbrook Laboratories

Halyard

Forest Laboratories

Endo International

Elanco

Ceva Sante Animale

Boehringer Ingelheim

Veterinary Pain Medication Segment by Type

Injection Medicines

Oral Medicines

Veterinary Pain Medication Segment by Application

Veterinary Hospitals

Veterinary Clinics

Others

Veterinary Pain Medication Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Pain Medication market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Pain Medication and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Pain Medication.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Pain Medication market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Veterinary Pain Medication manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Veterinary Pain Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Veterinary Pain Medication in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Veterinary Pain Medication Industry Trends Table 2. Veterinary Pain Medication Industry Drivers Table 3. Veterinary Pain Medication Industry Opportunities and Challenges Table 4. Veterinary Pain Medication Industry Restraints Table 5. Global Veterinary Pain Medication Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Veterinary Pain Medication Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Veterinary Pain Medication Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Veterinary Pain Medication Sales Market Share by Manufacturers Table 9. Global Veterinary Pain Medication Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Veterinary Pain Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Veterinary Pain Medication Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Veterinary Pain Medication Manufacturers, Product Type & Application Table 13. Global Veterinary Pain Medication Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Pain Medication by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Injection Medicines Table 17. Major Manufacturers of Oral Medicines Table 18. Global Veterinary Pain Medication Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Veterinary Pain Medication Sales by Type (2021-2026) & (k units) Table 20. Global Veterinary Pain Medication Sales by Type (2027-2032) & (k units) Table 21. Global Veterinary Pain Medication Sales Market Share by Type (2021-2026) Table 22. Global Veterinary Pain Medication Sales Market Share by Type (2027-2032) Table 23. Global Veterinary Pain Medication Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Veterinary Pain Medication Revenue by Type (2021-2026) & (k units) Table 25. Global Veterinary Pain Medication Revenue by Type (2027-2032) & (k units) Table 26. Global Veterinary Pain Medication Revenue Market Share by Type (2021-2026) Table 27. Global Veterinary Pain Medication Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Veterinary Hospitals Table 29. Major Manufacturers of Veterinary Clinics Table 30. Major Manufacturers of Others Table 31. Global Veterinary Pain Medication Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Veterinary Pain Medication Sales by Application (2021-2026) & (k units) Table 33. Global Veterinary Pain Medication Sales by Application (2027-2032) & (k units) Table 34. Global Veterinary Pain Medication Sales Market Share by Application (2021-2026) Table 35. Global Veterinary Pain Medication Sales Market Share by Application (2027-2032) Table 36. Global Veterinary Pain Medication Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Veterinary Pain Medication Revenue by Application (2021-2026) & (k units) Table 38. Global Veterinary Pain Medication Revenue by Application (2027-2032) & (k units) Table 39. Global Veterinary Pain Medication Revenue Market Share by Application (2021-2026) Table 40. Global Veterinary Pain Medication Revenue Market Share by Application (2027-2032) Table 41. Global Veterinary Pain Medication Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Veterinary Pain Medication Sales by Region (2021-2026) & (k units) Table 43. Global Veterinary Pain Medication Sales Market Share by Region (2021-2026) Table 44. Global Veterinary Pain Medication Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Veterinary Pain Medication Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Veterinary Pain Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Veterinary Pain Medication Sales by Country (2021-2026) & (k units) Table 48. North America Veterinary Pain Medication Sales by Country (2027-2032) & (k units) Table 49. Europe Veterinary Pain Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Veterinary Pain Medication Sales by Country (2021-2026) & (k units) Table 51. Europe Veterinary Pain Medication Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Veterinary Pain Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Veterinary Pain Medication Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Veterinary Pain Medication Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Veterinary Pain Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Veterinary Pain Medication Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Veterinary Pain Medication Sales by Country (2027-2032) & (k units) Table 58. Global Veterinary Pain Medication Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Veterinary Pain Medication Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Veterinary Pain Medication Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Veterinary Pain Medication Revenue Market Share by Region (2021-2026) Table 62. Global Veterinary Pain Medication Revenue Market Share by Region (2027-2032) Table 63. Zoetis Company Information Table 64. Zoetis Business Overview Table 65. Zoetis Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Zoetis Veterinary Pain Medication Product Portfolio Table 67. Zoetis Recent Development Table 68. Ringpu Bio-technology Company Information Table 69. Ringpu Bio-technology Business Overview Table 70. Ringpu Bio-technology Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Ringpu Bio-technology Veterinary Pain Medication Product Portfolio Table 72. Ringpu Bio-technology Recent Development Table 73. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Information Table 74. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Business Overview Table 75. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio Table 77. Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Recent Development Table 78. Merck & Co Company Information Table 79. Merck & Co Business Overview Table 80. Merck & Co Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Merck & Co Veterinary Pain Medication Product Portfolio Table 82. Merck & Co Recent Development Table 83. Medtronic Company Information Table 84. Medtronic Business Overview Table 85. Medtronic Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Medtronic Veterinary Pain Medication Product Portfolio Table 87. Medtronic Recent Development Table 88. Lilly Company Information Table 89. Lilly Business Overview Table 90. Lilly Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Lilly Veterinary Pain Medication Product Portfolio Table 92. Lilly Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. Pfizer Veterinary Pain Medication Product Portfolio Table 97. Pfizer Recent Development Table 98. Harbin Bolai Pharmaceutical Co., Ltd. Company Information Table 99. Harbin Bolai Pharmaceutical Co., Ltd. Business Overview Table 100. Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio Table 102. Harbin Bolai Pharmaceutical Co., Ltd. Recent Development Table 103. Bostonscientific Company Information Table 104. Bostonscientific Business Overview Table 105. Bostonscientific Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Bostonscientific Veterinary Pain Medication Product Portfolio Table 107. Bostonscientific Recent Development Table 108. Bayer Pharma AG Company Information Table 109. Bayer Pharma AG Business Overview Table 110. Bayer Pharma AG Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Bayer Pharma AG Veterinary Pain Medication Product Portfolio Table 112. Bayer Pharma AG Recent Development Table 113. Baxter Company Information Table 114. Baxter Business Overview Table 115. Baxter Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Baxter Veterinary Pain Medication Product Portfolio Table 117. Baxter Recent Development Table 118. Norbrook Laboratories Company Information Table 119. Norbrook Laboratories Business Overview Table 120. Norbrook Laboratories Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Norbrook Laboratories Veterinary Pain Medication Product Portfolio Table 122. Norbrook Laboratories Recent Development Table 123. Halyard Company Information Table 124. Halyard Business Overview Table 125. Halyard Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Halyard Veterinary Pain Medication Product Portfolio Table 127. Halyard Recent Development Table 128. Forest Laboratories Company Information Table 129. Forest Laboratories Business Overview Table 130. Forest Laboratories Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Forest Laboratories Veterinary Pain Medication Product Portfolio Table 132. Forest Laboratories Recent Development Table 133. Endo International Company Information Table 134. Endo International Business Overview Table 135. Endo International Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Endo International Veterinary Pain Medication Product Portfolio Table 137. Endo International Recent Development Table 138. Elanco Company Information Table 139. Elanco Business Overview Table 140. Elanco Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Elanco Veterinary Pain Medication Product Portfolio Table 142. Elanco Recent Development Table 143. Ceva Sante Animale Company Information Table 144. Ceva Sante Animale Business Overview Table 145. Ceva Sante Animale Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Ceva Sante Animale Veterinary Pain Medication Product Portfolio Table 147. Ceva Sante Animale Recent Development Table 148. Boehringer Ingelheim Company Information Table 149. Boehringer Ingelheim Business Overview Table 150. Boehringer Ingelheim Veterinary Pain Medication Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Boehringer Ingelheim Veterinary Pain Medication Product Portfolio Table 152. Boehringer Ingelheim Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Veterinary Pain Medication Distributors List Table 156. Veterinary Pain Medication Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Veterinary Pain Medication Product Image Figure 2. Global Veterinary Pain Medication Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Pain Medication Market Size (2021-2032) & (US$ Million) Figure 4. Global Veterinary Pain Medication Sales (2021-2032) & (k units) Figure 5. Global Veterinary Pain Medication Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Veterinary Pain Medication Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Injection Medicines Image Figure 9. Oral Medicines Image Figure 10. Global Veterinary Pain Medication Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Veterinary Pain Medication Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Veterinary Pain Medication Sales Market Share by Type (2021-2032) Figure 13. Global Veterinary Pain Medication Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Veterinary Pain Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Veterinary Pain Medication Revenue Market Share by Type (2021-2032) Figure 16. Veterinary Hospitals Image Figure 17. Veterinary Clinics Image Figure 18. Others Image Figure 19. Global Veterinary Pain Medication Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Veterinary Pain Medication Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Veterinary Pain Medication Sales Market Share by Application (2021-2032) Figure 22. Global Veterinary Pain Medication Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Veterinary Pain Medication Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Veterinary Pain Medication Revenue Market Share by Application (2021-2032) Figure 25. North America Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Veterinary Pain Medication Sales Market Share by Country (2021-2032) Figure 27. U.S. Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Veterinary Pain Medication Sales Market Share by Country (2021-2032) Figure 32. Germany Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Veterinary Pain Medication Sales Market Share by Country (2021-2032) Figure 39. China Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Veterinary Pain Medication Sales Market Share by Country (2021-2032) Figure 47. Brazil Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Veterinary Pain Medication Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Veterinary Pain Medication Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Veterinary Pain Medication Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Figure 58. North America Veterinary Pain Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Figure 60. Europe Veterinary Pain Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Veterinary Pain Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Veterinary Pain Medication Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Veterinary Pain Medication Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Veterinary Pain Medication Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Veterinary Pain Medication Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Injection Medicines
  • Oral Medicines
Applications
  • Veterinary Hospitals
  • Veterinary Clinics
  • Others
Companies covered
  • Zoetis
  • Ringpu Bio-technology
  • Ruicheng Lvman Biological Pharmaceutical Co., Ltd.
  • Merck & Co
  • Medtronic
  • Lilly
  • Pfizer
  • Harbin Bolai Pharmaceutical Co., Ltd.
  • Bostonscientific
  • Bayer Pharma AG
  • Baxter
  • Norbrook Laboratories
  • Halyard
  • Forest Laboratories
  • Endo International
  • Elanco
  • Ceva Sante Animale
  • Boehringer Ingelheim

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Veterinary Pain Medication Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Veterinary Pain Medication Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Veterinary Pain Medication Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Veterinary Pain Medication Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Veterinary Pain Medication Market Dynamics
  1. 2.1 Veterinary Pain Medication Industry Trends
  2. 2.2 Veterinary Pain Medication Industry Drivers
  3. 2.3 Veterinary Pain Medication Industry Opportunities and Challenges
  4. 2.4 Veterinary Pain Medication Industry Restraints
3 Veterinary Pain Medication Market by Manufacturers
  1. 3.1 Global Veterinary Pain Medication Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Veterinary Pain Medication Sales by Manufacturers (2021-2026)
  3. 3.3 Global Veterinary Pain Medication Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Veterinary Pain Medication Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Veterinary Pain Medication Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Veterinary Pain Medication Manufacturers, Product Type & Application
  7. 3.7 Global Veterinary Pain Medication Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Veterinary Pain Medication Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Veterinary Pain Medication Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Veterinary Pain Medication Tier 1, Tier 2, and Tier 3
4 Veterinary Pain Medication Market by Type
  1. 4.1 Veterinary Pain Medication Type Introduction
  2. 4.1.1 Injection Medicines
  3. 4.1.2 Oral Medicines
  4. 4.2 Global Veterinary Pain Medication Sales by Type
  5. 4.2.1 Global Veterinary Pain Medication Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Veterinary Pain Medication Sales by Type (2021-2032)
  7. 4.2.3 Global Veterinary Pain Medication Sales Market Share by Type (2021-2032)
  8. 4.3 Global Veterinary Pain Medication Revenue by Type
  9. 4.3.1 Global Veterinary Pain Medication Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Veterinary Pain Medication Revenue by Type (2021-2032)
  11. 4.3.3 Global Veterinary Pain Medication Revenue Market Share by Type (2021-2032)
5 Veterinary Pain Medication Market by Application
  1. 5.1 Veterinary Pain Medication Application Introduction
  2. 5.1.1 Veterinary Hospitals
  3. 5.1.2 Veterinary Clinics
  4. 5.1.3 Others
  5. 5.2 Global Veterinary Pain Medication Sales by Application
  6. 5.2.1 Global Veterinary Pain Medication Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Pain Medication Sales by Application (2021-2032)
  8. 5.2.3 Global Veterinary Pain Medication Sales Market Share by Application (2021-2032)
  9. 5.3 Global Veterinary Pain Medication Revenue by Application
  10. 5.3.1 Global Veterinary Pain Medication Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Veterinary Pain Medication Revenue by Application (2021-2032)
  12. 5.3.3 Global Veterinary Pain Medication Revenue Market Share by Application (2021-2032)
6 Global Veterinary Pain Medication Sales by Region
  1. 6.1 Global Veterinary Pain Medication Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Pain Medication Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Pain Medication Sales by Region (2021-2026)
  4. 6.2.2 Global Veterinary Pain Medication Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Veterinary Pain Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Veterinary Pain Medication Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Veterinary Pain Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Veterinary Pain Medication Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Veterinary Pain Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Veterinary Pain Medication Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Veterinary Pain Medication Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Veterinary Pain Medication Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Veterinary Pain Medication Revenue by Region
  1. 7.1 Global Veterinary Pain Medication Revenue by Region
  2. 7.1.1 Global Veterinary Pain Medication Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Veterinary Pain Medication Revenue by Region (2021-2026)
  4. 7.1.3 Global Veterinary Pain Medication Revenue by Region (2027-2032)
  5. 7.1.4 Global Veterinary Pain Medication Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Veterinary Pain Medication Revenue (2021-2032)
  8. 7.2.2 North America Veterinary Pain Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Veterinary Pain Medication Revenue (2021-2032)
  11. 7.3.2 Europe Veterinary Pain Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Veterinary Pain Medication Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Veterinary Pain Medication Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Veterinary Pain Medication Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Veterinary Pain Medication Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Zoetis
  2. 8.1.1 Zoetis Company Information
  3. 8.1.2 Zoetis Business Overview
  4. 8.1.3 Zoetis Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Zoetis Veterinary Pain Medication Product Portfolio
  6. 8.1.5 Zoetis Recent Developments
  7. 8.2 Ringpu Bio-technology
  8. 8.2.1 Ringpu Bio-technology Company Information
  9. 8.2.2 Ringpu Bio-technology Business Overview
  10. 8.2.3 Ringpu Bio-technology Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Ringpu Bio-technology Veterinary Pain Medication Product Portfolio
  12. 8.2.5 Ringpu Bio-technology Recent Developments
  13. 8.3 Ruicheng Lvman Biological Pharmaceutical Co., Ltd.
  14. 8.3.1 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio
  18. 8.3.5 Ruicheng Lvman Biological Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Merck & Co
  20. 8.4.1 Merck & Co Company Information
  21. 8.4.2 Merck & Co Business Overview
  22. 8.4.3 Merck & Co Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Merck & Co Veterinary Pain Medication Product Portfolio
  24. 8.4.5 Merck & Co Recent Developments
  25. 8.5 Medtronic
  26. 8.5.1 Medtronic Company Information
  27. 8.5.2 Medtronic Business Overview
  28. 8.5.3 Medtronic Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Medtronic Veterinary Pain Medication Product Portfolio
  30. 8.5.5 Medtronic Recent Developments
  31. 8.6 Lilly
  32. 8.6.1 Lilly Company Information
  33. 8.6.2 Lilly Business Overview
  34. 8.6.3 Lilly Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Lilly Veterinary Pain Medication Product Portfolio
  36. 8.6.5 Lilly Recent Developments
  37. 8.7 Pfizer
  38. 8.7.1 Pfizer Company Information
  39. 8.7.2 Pfizer Business Overview
  40. 8.7.3 Pfizer Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Pfizer Veterinary Pain Medication Product Portfolio
  42. 8.7.5 Pfizer Recent Developments
  43. 8.8 Harbin Bolai Pharmaceutical Co., Ltd.
  44. 8.8.1 Harbin Bolai Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Harbin Bolai Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Harbin Bolai Pharmaceutical Co., Ltd. Veterinary Pain Medication Product Portfolio
  48. 8.8.5 Harbin Bolai Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Bostonscientific
  50. 8.9.1 Bostonscientific Company Information
  51. 8.9.2 Bostonscientific Business Overview
  52. 8.9.3 Bostonscientific Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Bostonscientific Veterinary Pain Medication Product Portfolio
  54. 8.9.5 Bostonscientific Recent Developments
  55. 8.10 Bayer Pharma AG
  56. 8.10.1 Bayer Pharma AG Company Information
  57. 8.10.2 Bayer Pharma AG Business Overview
  58. 8.10.3 Bayer Pharma AG Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Bayer Pharma AG Veterinary Pain Medication Product Portfolio
  60. 8.10.5 Bayer Pharma AG Recent Developments
  61. 8.11 Baxter
  62. 8.11.1 Baxter Company Information
  63. 8.11.2 Baxter Business Overview
  64. 8.11.3 Baxter Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Baxter Veterinary Pain Medication Product Portfolio
  66. 8.11.5 Baxter Recent Developments
  67. 8.12 Norbrook Laboratories
  68. 8.12.1 Norbrook Laboratories Company Information
  69. 8.12.2 Norbrook Laboratories Business Overview
  70. 8.12.3 Norbrook Laboratories Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Norbrook Laboratories Veterinary Pain Medication Product Portfolio
  72. 8.12.5 Norbrook Laboratories Recent Developments
  73. 8.13 Halyard
  74. 8.13.1 Halyard Company Information
  75. 8.13.2 Halyard Business Overview
  76. 8.13.3 Halyard Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Halyard Veterinary Pain Medication Product Portfolio
  78. 8.13.5 Halyard Recent Developments
  79. 8.14 Forest Laboratories
  80. 8.14.1 Forest Laboratories Company Information
  81. 8.14.2 Forest Laboratories Business Overview
  82. 8.14.3 Forest Laboratories Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Forest Laboratories Veterinary Pain Medication Product Portfolio
  84. 8.14.5 Forest Laboratories Recent Developments
  85. 8.15 Endo International
  86. 8.15.1 Endo International Company Information
  87. 8.15.2 Endo International Business Overview
  88. 8.15.3 Endo International Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Endo International Veterinary Pain Medication Product Portfolio
  90. 8.15.5 Endo International Recent Developments
  91. 8.16 Elanco
  92. 8.16.1 Elanco Company Information
  93. 8.16.2 Elanco Business Overview
  94. 8.16.3 Elanco Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Elanco Veterinary Pain Medication Product Portfolio
  96. 8.16.5 Elanco Recent Developments
  97. 8.17 Ceva Sante Animale
  98. 8.17.1 Ceva Sante Animale Company Information
  99. 8.17.2 Ceva Sante Animale Business Overview
  100. 8.17.3 Ceva Sante Animale Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Ceva Sante Animale Veterinary Pain Medication Product Portfolio
  102. 8.17.5 Ceva Sante Animale Recent Developments
  103. 8.18 Boehringer Ingelheim
  104. 8.18.1 Boehringer Ingelheim Company Information
  105. 8.18.2 Boehringer Ingelheim Business Overview
  106. 8.18.3 Boehringer Ingelheim Veterinary Pain Medication Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Boehringer Ingelheim Veterinary Pain Medication Product Portfolio
  108. 8.18.5 Boehringer Ingelheim Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Pain Medication Value Chain Analysis
  2. 9.1.1 Veterinary Pain Medication Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Pain Medication Production Mode & Process
  6. 9.2 Veterinary Pain Medication Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Pain Medication Distributors
  9. 9.2.3 Veterinary Pain Medication Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst